Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CLX 0921, a PPAR gamma agonist, is used potentially for the treatment of type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CLX 0921, a PPAR gamma agonist, is used potentially for the treatment of type 2 diabetes. |
Synonyms | THR0921, CLX0921, CLX-0921, THR 0921, THR-0921 |
Molecular Weight | 519.57 |
Formula | C28H25NO7S |
CAS No. | 249886-47-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CLX 0921 249886-47-3 THR0921 CLX0921 CLX-0921 THR 0921 THR-0921 inhibitor inhibit